Medical Plastics Market Report 2026

Medical Plastics Market Overview

• Medical Plastics market size has reached to $37.66 billion in 2025 • Expected to grow to $62.79 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Increasing Use Of Single Use Medical Plastics Fueling The Growth Of The Market Due To Rising Infection Control Requirements And Patient Safety Priorities • Market Trend: Regenerative Polymer-Ceramic Bioactive Matrices With Digital Monitoring Transform Postoperative Care • Asia-Pacific was the largest region in 2025.

What Is Covered Under Medical Plastics Market?

Medical plastics refer to plastic products specifically used in the healthcare industry. Medical plastics are resistant to temperature, corrosion, and chemicals making them the right fit for use in medical applications. Medical plastics are used for manufacturing and packaging applications in medical products. The main type medical plastics are polyvinyl chloride (PVC), polypropylene (pp), engineering plastics, polyethylene (PE), polystyrene (PS), silicones and others. The polyvinyl chloride (PVC) plastic are economical and versatile thermoplastic polymers widely used in medical devices. The process technology used in medical plastics are extrusion, injection molding, blow molding and others (including rotational molding and compression molding). Medical plastics are used in medical disposables, medical instruments, prosthetics & implants, drugs packaging and others.

What Is The Medical Plastics Market Growth Forecast?

The medical plastics market size is expected to see rapid growth in the next few years. It will grow to $62.79 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of sustainable plastics, rising demand for precision-molded components, expansion of implantable plastic devices, growing focus on lightweight medical instruments, advancements in medical-grade polymer formulations. Major trends in the forecast period include increasing use of high-performance medical plastics, rising demand for disposable medical products, growing adoption of advanced molding technologies, expansion of bio-based medical plastics, enhanced focus on sterilization compatibility.

What Is The Driver Of The Medical Plastics Market?

The increasing use of single use medical plastics is expected to propel the growth of the medical plastics market going forward. Single use medical plastics are disposable polymer-based products used in healthcare settings to maintain sterility, prevent cross-contamination, and support infection control. The increase in single use medical plastics is driven by stricter infection control protocols and heightened focus on patient safety in hospitals and clinics. Rising single-use medical plastics support the broader medical plastics sector by driving continuous demand, accelerating innovation in safer and more efficient materials, and reinforcing the industry’s role in delivering sterile, reliable, and cost-effective healthcare solutions. For instance, in September 2025, according to the systemiq Ltd., a UK-based capital marketing company, the U.S. and Canada generated approximately 1.2?million metric tons of single use healthcare plastic waste in 2023, while Europe produced another 0.9?million metric tons. Therefore, the increasing use of single use medical plastics is driving the growth of the medical plastics industry.

Key Players In The Global Medical Plastics Market

Major companies operating in the medical plastics market are BASF SE, Celanese Corporation, Solvay S.A., Arkema SA, Eastman Chemical Company, Dow Inc., Saudi Arabia's Basic Industries Corporation, Evonik Industries AG, Röchling SE & Co. KG, Nolato AB, Saint-Gobain Performance Plastics, Orthoplastics Ltd., Tekni-Plex Inc., HMC Polymers Co. Ltd., ARAN BIOMEDICAL TEORANTA, Trelleborg AB, Raumedic AG, Ensinger GmbH, RTP Company Inc., Foster Corporation, PolyOne Corporation, DSM Engineering Plastics Pvt. Ltd., Covestro AG, DuPont de Nemours Inc., Exxon Mobil Corporation, Lubrizol Corporation, Trinseo LLC, Mitsubishi Chemical Corporation, Sumitomo Chemical Co. Ltd., Kuraray Co. Ltd.

Global Medical Plastics Market Trends and Insights

Major companies operating in the medical plastics market are focusing on developing innovative solutions, such as advanced biomaterial-integrated digital health platforms, to meet the rising demand for minimally invasive medical devices and enhanced patient outcomes. Advanced biomaterial-integrated digital health platforms combine biocompatible plastics with smart sensors and digital interfaces, enabling real-time monitoring and improved tissue integration compared to traditional single-material medical plastics, which primarily focus on structural functionality without embedded digital capabilities. For instance, in January 2024, Xenco Medical, a US-based medical device company, launched the Trabeculex Continuum, an innovative convergence of digital health and biomaterials designed to transform spinal and orthopedic procedures. The Trabeculex Continuum incorporates proprietary biocompatible polymers that mimic bone microarchitecture, integrated with sensors that provide intraoperative feedback and post-operative monitoring, enhancing precision, reducing complications, and accelerating patient recovery. Its unique combination of structural support, biomimetic properties, and digital integration represents a significant advancement over conventional implants, which typically rely solely on passive plastic or metal materials.

What Are Latest Mergers And Acquisitions In The Medical Plastics Market?

In July 2024, DuPont, a US based chemical company, acquired Donatelle Plastics for an undisclosed amount. The acquisition of Donatelle introduces complementary advanced technologies and capabilities, such as medical device injection molding and liquid silicone rubber processing. Additionally, it enhances precision machining, device assembly, and tool building capabilities within the organization. Donatelle Plastics is a US-based manufacturer of medical plastic products.

What Defines the Medical Plastics Market?

The medical plastics market consists of sales of polycarbonate, acrylonitrile butadiene styrene (ABS), polyethylene terephthalate glycol (PETG), and polymethyl methacrylate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Medical Plastics Market Report 2026?

The medical plastics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical plastics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.